Achieve Life Sciences (ACHV) Change in Accured Expenses (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Change in Accured Expenses data on file, last reported at $261000.0 in Q1 2026.

• Quarterly Change in Accured Expenses rose 112.65% year-over-year to $261000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 1129.29% YoY) and the FY2025 annual result came in at -$1.1 million, down 254.75% from the prior year.
• Change in Accured Expenses advanced to $261000.0 in Q1 2026, from -$510000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.7 million in Q2 2025 to a low of -$2.1 million in Q1 2025.
• A 5-year average of $14058.8 and a median of $261000.0 in 2026 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2024 — Change in Accured Expenses soared 576.27% — and 2025, when it tumbled 542.7%.
• Tracing ACHV's Change in Accured Expenses over 5 years: stood at $287000.0 in 2022, then grew by 12.54% to $323000.0 in 2023, then sank by 47.68% to $169000.0 in 2024, then tumbled by 401.78% to -$510000.0 in 2025, then jumped by 151.18% to $261000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $261000.0 (Q1 2026), -$510000.0 (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.